Odyssey Group International Inc. (ODYY)
| Market Cap | 61.89M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.91M |
| Shares Out | 99.82M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 10 |
| Last Price | $0.6600 |
| Previous Close | $0.7000 |
| Change ($) | -0.0400 |
| Change (%) | -5.71% |
| Day's Open | 0.7750 |
| Day's Range | 0.6100 - 0.7750 |
| Day's Volume | 65,106 |
| 52-Week Range | 0.1050 - 3.1000 |
IRVINE, CA, May 13, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"),a technology and asset acquisition company focused on developing unique, life-...
Irvine, CA, April 14, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, lif...
CEO Michael Redmond to Highlight the Company's Strategy in Developing and Acquiring Life-Saving Medical Products IRVINE, CA / ACCESSWIRE / March 22, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY)...
Inaugural members of the Sports Advisory Board (SAB) include Kurt Warner, Brett Favre, Mark Rypien, David Ross and Steve “Mooch” Mariucci Inaugural members of the Sports Advisory Board (SAB) include Kur...
IRVINE, CA / ACCESSWIRE / March 10, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-savi...
Anticipates initiation of Phase 1 clinical trials of PRV-002 during the Second Quarter of 2021 IRVINE, CA / ACCESSWIRE / March 2, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) ("Odyssey"), a tec...
All Stock Transaction Phase 1 Clinical Trial Site, Protocol and CRO Established IRVINE, CA / ACCESSWIRE / January 11, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the “Company” or “Odyssey”), ...
About ODYY
Odyssey Group International, Inc. focuses on development, acquisition, and commercialization of medical products and health related technologies. It intends to offer medical devices. The company has development projects in three technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat rare brain disorders. Odyssey Group International, Inc. was founded in 2014 and is based in Irvine, California.
| Industry Medical Devices | Founded 2014 |
| Stock Exchange OTCMKTS | Ticker Symbol ODYY |